Russell Investments Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,964
| Closed | -$10K | – | 2935 |
|
|
2022
Q1 | $10K | Hold |
6,964
| – | – | ﹤0.01% | 2709 |
|
|
2021
Q4 | $17K | Sell |
6,964
-5,420
| -44% | -$13.2K | ﹤0.01% | 2958 |
|
|
2021
Q3 | $31K | Sell |
12,384
-3,402
| -22% | -$8.52K | ﹤0.01% | 2976 |
|
|
2021
Q2 | $44K | Buy |
+15,786
| New | +$44K | ﹤0.01% | 3138 |
|
|
2020
Q3 | – | Sell |
-761,830
| Closed | -$665K | – | 3223 |
|
|
2020
Q2 | $665K | Buy |
+761,830
| New | +$665K | ﹤0.01% | 2263 |
|
|
2018
Q3 | – | Sell |
-35,778
| Closed | -$65K | – | 2987 |
|
|
2018
Q2 | $65K | Buy |
35,778
+2,514
| +8% | +$4.57K | ﹤0.01% | 2787 |
|
|
2018
Q1 | $78K | Sell |
33,264
-13,830
| -29% | -$32.4K | ﹤0.01% | 2778 |
|
|
2017
Q4 | $92K | Sell |
47,094
-12,801
| -21% | -$25K | ﹤0.01% | 2793 |
|
|
2017
Q3 | $149K | Sell |
59,895
-62,932
| -51% | -$157K | ﹤0.01% | 2718 |
|
|
2017
Q2 | $339K | Buy |
122,827
+12,753
| +12% | +$35.2K | ﹤0.01% | 2552 |
|
|
2017
Q1 | $333K | Buy |
110,074
+83,009
| +307% | +$251K | ﹤0.01% | 2571 |
|
|
2016
Q4 | $86K | Buy |
+27,065
| New | +$86K | ﹤0.01% | 2907 |
|